<DOC>
	<DOC>NCT01425411</DOC>
	<brief_summary>The study hypothesis: Valsartan as an angiotensin II receptor blocker treatment has beneficial effects on both midwall mechanics and myocardial functions in hypertensive patients with Left ventricular hypertrophy.</brief_summary>
	<brief_title>Effect of Valsartan on Left Ventricular Myocardial Functions in Hypertensive Patients With Left Ventricular Hypertrophy</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Hypertrophy</mesh_term>
	<mesh_term>Hypertrophy, Left Ventricular</mesh_term>
	<mesh_term>Valsartan</mesh_term>
	<criteria>hypertension with left ventricular hypertrophy clinical or laboratory evidence of secondary hypertension heart failure ischemic heart disease valvular heart disease arrhythmias peripheral vascular disease chronic obstructive pulmonary disease neurologic disorders diabetes mellitus renal dysfunction notable systemic disease</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>August 2011</verification_date>
	<keyword>hypertension</keyword>
	<keyword>left ventricular hypertrophy</keyword>
	<keyword>angiotensin receptor blocker</keyword>
	<keyword>midwall mechanics</keyword>
	<keyword>tissue Doppler imaging</keyword>
	<keyword>Hypertension with left ventricular hypertrophy</keyword>
</DOC>